Understanding the Market | UNISOUND rose over 12% in the afternoon, up 1.2 times from the offering price, as the company focuses on smart living and smart healthcare sectors
UNISOUND's stock price rose over 12% in the afternoon, reaching a new high since its listing, an increase of over 126% compared to the offering price. As of the time of writing, the stock price is HKD 456.8, with a trading volume of HKD 25.3185 million. The company signed a strategic cooperation agreement with the Guangxi Health and Family Planning Commission to promote the application of medical AI technology in the regional health system. At the same time, UNISOUND reached a strategic cooperation with Runjian Co., Ltd. to promote the application of AI technology in multiple fields. UNISOUND is the fourth largest AI solution provider in China, with a market share of 0.6%
According to the Zhitong Finance APP, UNISOUND (09678) rose over 12% in the afternoon, reaching a new high of HKD 463.8, an increase of over 126% compared to the IPO price of HKD 205. As of the time of writing, it is up 10.61%, trading at HKD 456.8, with a transaction volume of HKD 25.3185 million.
In terms of news, UNISOUND recently signed a strategic cooperation framework agreement with the Health Commission of Guangxi Zhuang Autonomous Region. This cooperation marks the comprehensive and in-depth participation of UNISOUND's medical AI technology in the digital and intelligent construction of Guangxi's health system, injecting core momentum into the high-quality development of regional healthcare. Additionally, Runjian Co., Ltd. and UNISOUND have officially reached a strategic cooperation agreement. The two parties will conduct in-depth collaboration around AI technology innovation and industrial implementation, jointly promoting the large-scale application of AI technology in fields such as communication, energy, education, healthcare, and government affairs.
Public information shows that UNISOUND is an AI solution provider that promotes the implementation of AI technology around two core scenarios: "smart living" and "smart healthcare," and has formed a clear business landscape. According to Frost & Sullivan, in terms of revenue, the company remains the fourth largest AI solution provider in China during the historical record period, with a market share of 0.6%. The market size of China's AI solution market is expected to increase by 33.1% from RMB 135.5 billion in 2023 to RMB 180.4 billion in 2024, while the company's revenue is projected to grow by 29.1% from RMB 727 million in 2023 to RMB 939 million in 2024. In 2024, in terms of revenue, the company ranks third in China's daily life AI solutions and fourth in medical AI solutions
